242 related articles for article (PubMed ID: 31157860)
1. Is microwave ablation an alternative to stereotactic ablative body radiotherapy in patients with inoperable early-stage primary lung cancer?
Watson RA; Tol I; Gunawardana S; Tsakok MT
Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):539-543. PubMed ID: 31157860
[TBL] [Abstract][Full Text] [Related]
2. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?
Bilal H; Mahmood S; Rajashanker B; Shah R
Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):258-65. PubMed ID: 22581864
[TBL] [Abstract][Full Text] [Related]
3. Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery?
Renaud S; Falcoz PE; Olland A; Massard G
Interact Cardiovasc Thorac Surg; 2013 Jan; 16(1):68-73. PubMed ID: 23054908
[TBL] [Abstract][Full Text] [Related]
4. Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation.
Franzese C; Comito T; Clerici E; Di Brina L; Tomatis S; Navarria P; Reggiori G; Viganò L; Poretti D; Pedicini V; Torzilli G; Solbiati L; Scorsetti M
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1777-1783. PubMed ID: 29934790
[TBL] [Abstract][Full Text] [Related]
5. Unresectable Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial.
van der Lei S; Dijkstra M; Nieuwenhuizen S; Schulz HH; Vos DJW; Versteeg KS; Buffart TE; Swijnenburg RJ; de Vries JJJ; Bruynzeel AME; van den Tol MP; Scheffer HJ; Puijk RS; Haasbeek CJA; Meijerink MR;
Cardiovasc Intervent Radiol; 2023 Aug; 46(8):1076-1085. PubMed ID: 37430016
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases.
Yang X; Ye X; Zheng A; Huang G; Ni X; Wang J; Han X; Li W; Wei Z
J Surg Oncol; 2014 Nov; 110(6):758-63. PubMed ID: 24965604
[TBL] [Abstract][Full Text] [Related]
7. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?
Mahmood S; Bilal H; Faivre-Finn C; Shah R
Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):845-53. PubMed ID: 23900381
[TBL] [Abstract][Full Text] [Related]
8. Is stereotactic radiotherapy equivalent to metastasectomy in patients with pulmonary oligometastases?
Li S; Nie S; Li Z; Che G
Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):544-550. PubMed ID: 31180484
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Body Radiation Therapy Versus Nonradiotherapeutic Ablative Procedures (Laser/Cryoablation and Electrocautery) for Early-Stage Non-Small Cell Lung Cancer.
Baine MJ; Sleightholm R; Neilsen BK; Oupický D; Smith LM; Verma V; Lin C
J Natl Compr Canc Netw; 2019 May; 17(5):450-458. PubMed ID: 31085762
[TBL] [Abstract][Full Text] [Related]
10. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.
Rwigema JC; Chen AM; Wang PC; Lee JM; Garon E; Lee P
Clin Lung Cancer; 2014 Jul; 15(4):287-93. PubMed ID: 24594401
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis.
Laeseke P; Ng C; Ferko N; Naghi A; Wright GWJ; Zhang Y; Laidlaw A; Kalsekar I; Laxmanan B; Ghosh SK; Zhou M; Szapary P; Pritchett M
Lung Cancer; 2023 Aug; 182():107259. PubMed ID: 37321074
[TBL] [Abstract][Full Text] [Related]
12. Microwave Ablation (MWA) of Pulmonary Neoplasms: Clinical Performance of High-Frequency MWA With Spatial Energy Control Versus Conventional Low-Frequency MWA.
Vogl TJ; Basten LM; Nour-Eldin NA; Kaltenbach B; Ackermann H; Naguib NNN
AJR Am J Roentgenol; 2019 Dec; 213(6):1388-1396. PubMed ID: 31593520
[No Abstract] [Full Text] [Related]
13. Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence?
Palussière J; Cazayus M; Cousin S; Cabart M; Chomy F; Catena V; Buy X
Curr Oncol Rep; 2021 May; 23(7):81. PubMed ID: 33948744
[TBL] [Abstract][Full Text] [Related]
14. Microwave Ablation versus Stereotactic Body Radiotherapy for Stage I Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis.
Wu X; Uhlig J; Blasberg JD; Gettinger SN; Suh RD; Solomon SB; Kim HS
J Vasc Interv Radiol; 2022 Aug; 33(8):964-971.e2. PubMed ID: 35490932
[TBL] [Abstract][Full Text] [Related]
15. Effects of microwave ablation or its combination with whole-body chemotherapy on serum vascular endothelial growth factor levels in patients with stage IIIB/IV NSCLC.
Sun YH; Song PY; Guo Y; Pang M; He WN; Zhang WH; Sheng LJ
Genet Mol Res; 2015 Aug; 14(3):10015-25. PubMed ID: 26345938
[TBL] [Abstract][Full Text] [Related]
16. Thermal Ablation of Lung Tumors: Focus on Microwave Ablation.
Vogl TJ; Nour-Eldin NA; Albrecht MH; Kaltenbach B; Hohenforst-Schmidt W; Lin H; Panahi B; Eichler K; Gruber-Rouh T; Roman A
Rofo; 2017 Sep; 189(9):828-843. PubMed ID: 28511267
[No Abstract] [Full Text] [Related]
17. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
Bi N; Shedden K; Zheng X; Kong FS
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1378-1390. PubMed ID: 27479723
[TBL] [Abstract][Full Text] [Related]
19. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G; Simpson KH; Moghanaki D; Zhu AW
J Thorac Cardiovasc Surg; 2018 Jan; 155(1):395-402. PubMed ID: 28888379
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
Sher DJ; Wee JO; Punglia RS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
